Compare CUZ & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CUZ | TMDX |
|---|---|---|
| Founded | 1958 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.4B |
| IPO Year | 1994 | 2019 |
| Metric | CUZ | TMDX |
|---|---|---|
| Price | $22.60 | $109.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $28.33 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 1.6M | 903.7K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.76% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | 0.24 | ★ 4.87 |
| Revenue | ★ $993,816,000.00 | $605,494,000.00 |
| Revenue This Year | $4.19 | $24.51 |
| Revenue Next Year | $3.89 | $18.72 |
| P/E Ratio | $92.48 | ★ $22.03 |
| Revenue Growth | 16.00 | ★ 37.13 |
| 52 Week Low | $21.03 | $72.78 |
| 52 Week High | $30.80 | $156.00 |
| Indicator | CUZ | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 47.89 | 43.09 |
| Support Level | $21.11 | $99.95 |
| Resistance Level | $23.33 | $131.86 |
| Average True Range (ATR) | 0.73 | 5.40 |
| MACD | 0.11 | 0.77 |
| Stochastic Oscillator | 58.52 | 61.93 |
Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.